Triple Twelve Pharmaceuticals Private Limited
Founded in 2020 and headquartered in Kerala, India.
2020 | Thrissur, Kerala (India) | Active
Triple Twelve Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 346.64%
- Profit Growth 274.78%
- Ebitda 111.99%
- Net Worth 8.44%
- Total Assets 61.41%
About Triple Twelve Pharmaceuticals
Triple Twelve Pharmaceuticals Private Limited (TTPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 August 2020 (Four years and eight months 8 days old ). Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Padinjarekunnath Sreekumar, Sithara Sreekumar, and Sidharth Sreekumar serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230KL2020PTC063441
- Company No.
063441
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Chemicals
Pharmaceuticals
Triple Twelve Pharmaceuticals Private Limited
Explore comprehensive data for Triple Twelve Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Triple Twelve Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padinjarekunnath Sreekumar  | Managing Director | 05-Aug-2020 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sithara Sreekumar | Director | 05-Aug-2020 | Current |
| Sidharth Sreekumar | Director | 05-Aug-2020 | Current |
Financial Performance of Triple Twelve Pharmaceuticals.
Triple Twelve Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 346.64% increase. The company also saw a substantial improvement in profitability, with a 274.78% increase in profit. The company's net worth moved up by a moderate rise of 8.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Triple Twelve Pharmaceuticals?
Unlock access to Triple Twelve Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Triple Twelve Pharmaceuticals?
Triple Twelve Pharmaceuticals has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Triple Twelve Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triple Twelve Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Triple Twelve Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Triple Twelve Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Triple Twelve Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
- Director Appointment
Padinjarekunnath Sreekumar was appointed as a Managing Director was appointed as a Managing Director on 05 Aug 2020 & has been associated with this company since 4 years 8 months .
- Director Appointment
Sithara Sreekumar was appointed as a Director was appointed as a Director on 05 Aug 2020 & has been associated with this company since 4 years 8 months .
- Director Appointment
Sidharth Sreekumar was appointed as a Director was appointed as a Director on 05 Aug 2020 & has been associated with this company since 4 years 8 months .
- Company Incorporation
Triple Twelve Pharmaceuticals Private Limited was registered on 05 Aug 2020 with Roc Ernakulam & aged 4 years 8 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Triple Twelve Pharmaceuticals Private Limited?
Triple Twelve Pharmaceuticals Private Limited was incorporated on 05 Aug 2020.
What is authorized share capital and paid-up capital of Triple Twelve Pharmaceuticals Private Limited?
The authorized share capital of Triple Twelve Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Triple Twelve Pharmaceuticals Private Limited?
Currently 3 directors are associated with Triple Twelve Pharmaceuticals Private Limited.
- Padinjarekunnath Sreekumar
- Sithara Sreekumar
- Sidharth Sreekumar
What is the registered address of Triple Twelve Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Triple Twelve Pharmaceuticals Private Limited is Door No.35/473 A3 Cheraman Plaza, Pallinada India, Kodungallur, Kerala, 680664.
What is the corporate identification number (CIN) and company number of Triple Twelve Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Triple Twelve Pharmaceuticals Private Limited is U24230KL2020PTC063441 and the company number is 063441 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Triple Twelve Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Triple Twelve Pharmaceuticals Private Limited has risen by 346.64%.
What change has been observed in the net worth of Triple Twelve Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Triple Twelve Pharmaceuticals Private Limited has experienced an upsurge of 8.44%.
When was the last Balance Sheet of Triple Twelve Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Triple Twelve Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records